Aire Advisors LLC Buys 81 Shares of UnitedHealth Group Incorporated $UNH

Aire Advisors LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.0% in the second quarter, Holdings Channel.com reports. The fund owned 1,234 shares of the healthcare conglomerate’s stock after purchasing an additional 81 shares during the period. Aire Advisors LLC’s holdings in UnitedHealth Group were worth $385,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Citizens National Bank Trust Department boosted its position in shares of UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after acquiring an additional 170 shares during the last quarter. Caitlin John LLC raised its stake in UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after purchasing an additional 111 shares in the last quarter. Triumph Capital Management purchased a new stake in UnitedHealth Group during the second quarter valued at $1,324,000. Wealth Effects LLC raised its stake in UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after purchasing an additional 591 shares in the last quarter. Finally, Arlington Partners LLC purchased a new stake in UnitedHealth Group during the second quarter valued at $2,229,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.2%

NYSE UNH opened at $360.77 on Thursday. The company’s 50-day moving average price is $325.04 and its 200-day moving average price is $347.17. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $326.73 billion, a PE ratio of 15.63, a PEG ratio of 2.33 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Wednesday, October 8th. Truist Financial upped their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Sanford C. Bernstein boosted their price objective on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Seventeen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $384.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.